• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE APEX¿; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE APEX¿; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number H7493895940200
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code Perforation of Vessels (2135)
Date of Event 11/25/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).
 
Event or Problem Description
It was reported that balloon rupture and vessel perforation occurred.The target lesion was located in the posterior descending artery (pda).A 2.00mm x 40mm apex¿ balloon catheter was advanced for dilatation.However, during the first inflation at 12 atmospheres, the balloon ruptured.A perforation on the artery was then noted and a stent was deployed to cover the perforation.No patient complications were reported and the patient's status was fine.
 
Additional Manufacturer Narrative
Device evaluated by mfr: returned device consisted of a apex balloon catheter.The balloon was loosely folded, with blood and in the wire lumen, hub and balloon.The tip, balloon, hypotube and distal shaft were microscopically and tactile inspected.Inspection revealed a small pinhole in the balloon material at the distal edge of the distal markerband with numerous kinks in the hypotube.Inspection of the remainder of the device, apart from the observed damage, revealed no other damage or irregularities.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical procedural factors.(b)(4).
 
Event or Problem Description
It was reported that balloon rupture and vessel perforation occurred.The target lesion was located in the posterior descending artery (pda).A 2.00mm x 40mm apex¿ balloon catheter was advanced for dilatation.However, during the first inflation at 12 atmospheres, the balloon ruptured.A perforation on the artery was then noted and a stent was deployed to cover the perforation.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APEX¿
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
MDR Report Key6185163
Report Number2134265-2016-11804
Device Sequence Number1069844
Product Code LOX
UDI-Device Identifier08714729475910
UDI-Public(01)08714729475910(17)20190930(10)19776998
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P860019
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2019
Device Model NumberH7493895940200
Device Catalogue Number38959-4020
Device Lot Number19776998
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/07/2016
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 12/02/2016
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date12/19/2016
Supplement Report FDA Received Date01/26/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-